Patent application number | Description | Published |
20110213789 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR DETERMINING AN AMOUNT OF ACCESS TO DATA, BASED ON A ROLE - In accordance with embodiments, there are provided mechanisms and methods for determining an amount of access to data, based on a role. These mechanisms and methods for determining an amount of access to data, based on a role can enable enhanced data security, more relevant data display, increased time savings, etc. | 09-01-2011 |
20110246524 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR PORTAL USER DATA ACCESS IN A MULTI-TENANT ON-DEMAND DATABASE SYSTEM - In accordance with embodiments, there are provided mechanisms and methods for portal user data access in a multi-tenant on-demand database system. These mechanisms and methods for portal user data access in a multi-tenant on-demand database system can enable embodiments to provide portal-specific user accounts to the multi-tenant on-demand database system which have reduced configuration requirements than users directly accessing the multi-tenant on-demand database system. The ability of embodiments to provide portal-specific user accounts can reduce processing requirements of the database system. | 10-06-2011 |
20110270885 | SECURITY CONFIGURATION SYSTEMS AND METHODS FOR PORTAL USERS IN A MULTI-TENANT DATABASE ENVIRONMENT - A computer-implemented system and method includes method includes receiving a data request for data in a database from a user; determining if the user is an internal user or a portal user; consulting, if the user is the internal user, a first security setting associated with the data to determine if the requested data is public or private, and if the user is the portal user, consulting a second security setting separate from the first security setting to determine if the requested data is public or private; providing, if the requested data is public, access information to the user; performing, if the requested data is private, additional processing to determine if the user has access to the requested data. | 11-03-2011 |
20120203800 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR PORTAL USER DATA ACCESS IN A MULTI-TENANT ON-DEMAND DATABASE SYSTEM - In accordance with embodiments, there are provided mechanisms and methods for portal user data access in a multi-tenant on-demand database system. These mechanisms and methods for portal user data access in a multi-tenant on-demand database system can enable embodiments to provide portal-specific user accounts to the multi-tenant on-demand database system which have reduced configuration requirements than users directly accessing the multi-tenant on-demand database system. The ability of embodiments to provide portal-specific user accounts can reduce processing requirements of the database system. | 08-09-2012 |
20130198184 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR PORTAL USER DATA ACCESS IN A MULTI-TENANT ON-DEMAND DATABASE SYSTEM - In accordance with embodiments, there are provided mechanisms and methods for portal user data access in a multi-tenant on-demand database system. These mechanisms and methods for portal user data access in a multi-tenant on-demand database system can enable embodiments to provide portal-specific user accounts to the multi-tenant on-demand database system which have reduced configuration requirements than users directly accessing the multi-tenant on-demand database system. The ability of embodiments to provide portal-specific user accounts can reduce processing requirements of the database system. | 08-01-2013 |
Patent application number | Description | Published |
20120275792 | System and Method for Avoiding Upstream Interference in RF-Over-Glass Network - A headend communications device communicates via a network to downstream network elements, such as cable modems coupled behind optical network units, and allocates and grants timeslots for upstream transmissions from the network elements. The headend communications device has a scheduler for managing and controlling timeslot allocations in a manner avoiding interference such as optical beat interference or FM carrier collisions. The scheduler identifies two or more cable modems or like customer network elements served by the headend communications device that will cause at least a pre-determined intolerable level of interference when allocated overlapping timeslots for upstream transmissions and prevents these two or more cable modems or network elements from being allocated and granted overlapping timeslots. | 11-01-2012 |
20150280816 | OPTICAL BEAT INTERFERENCE DETECTION AND MITIGATION - An OBI manager provides the reduction/elimination of optical beat interference (OBI). As will be described in more detail below, the OBI manager identifies OBI partners through an identification process performed via an RFoG network. An OBI partner may be two optical networking units (ONUs) that may interfere with one another when transmitting in the same time slot. Once the OBI partners are identified, the OBI manager may perform a mitigation process to mitigate possible OBI. For example, the OBI manager may organize the OBI partners to reduce OBI, such as by guaranteeing no OBI partners transmit at the same time. | 10-01-2015 |
20150304042 | OPTICAL AND RF TECHNIQUES FOR AGGREGATION OF PHOTO DIODE ARRAYS - An active receiver structure that combines a large number of detectors without bandwidth penalty may provide a better signal-to-noise ratio (SNR) than conventional Radio Frequency over Glass (RFoG) networks. A transmission line receiver is used to combine a large number of optical detectors into a single radio frequency (RF) signal without a bandwidth penalty and a modest penalty in noise performance that results in an SNR that is much better than traditional optical combining techniques that are followed by a single detector. An optical multiplexer structure may be designed around the active splitter such that passive optical network (PON) operation is not impeded. | 10-22-2015 |
20160099778 | UPSTREAM INTERFERENCE ELIMINATING TRANSMISSION OF DIGITAL BASEBAND SIGNAL IN AN OPTICAL NETWORK - Particular embodiments provide a method for delivering data in the upstream direction without the need for upstream radio frequency (RF) modulation. For example, in some embodiments, an optical network may reach to a gateway associated with a user device. The gateway may receive digital baseband data from the user device in the upstream direction. The gateway can then send the digital baseband data through the optical network without modulating the digital baseband signal via radio frequency. At the headend, because no modulation is performed in the upstream direction, there is no need for de-modulation in the headend. In one embodiment, a scheduler-based approach is used to avoid instances of optical beat interference in the upstream direction as only one upstream device that may interfere with other devices may be able to send data at one time. | 04-07-2016 |
Patent application number | Description | Published |
20110294185 | MAGNETIC PLATFORMS FOR BIOMOLECULE TRAPPINGS, MANIPULATIONS, AND SORTING - A magnetic platform is provided and includes a patterned array of discrete magnetic elements positioned on a substrate, a plurality of first electromagnets for creating a first magnetic field substantially in the plane of the substrate, an electromagnetic coil for creating a second magnetic field substantially perpendicular to the plane of the substrate, and a control device for controlling the application of the magnetic fields. Processes for manipulating, transporting, separating and sorting micro- or nano-scale particles and biomolecules are also described. | 12-01-2011 |
20140199747 | MAGNETIC PLATFORMS FOR BIOMOLECULE TRAPPINGS, MANIPULATIONS, AND SORTING - A magnetic platform is provided and includes a patterned array of discrete magnetic elements positioned on a substrate, a plurality of first electromagnets for creating a first magnetic field substantially in the plane of the substrate, an electromagnetic coil for creating a second magnetic field substantially perpendicular to the plane of the substrate, and a control device for controlling the application of the magnetic fields. Processes for manipulating, transporting, separating and sorting micro- or nano-scale particles and biomolecules are also described. | 07-17-2014 |
Patent application number | Description | Published |
20090148342 | Hypochlorite Technology - This invention generally relates to compositions and method of producing diluted hypohalous acid and hypohalous acid vapor. These compositions can be used to treat allergen containing surfaces, hard surfaces, food contact surfaces, hospital surfaces, food surfaces, kitchen surfaces, bathroom surfaces, human surfaces, animal surfaces, children's items, outdoor surfaces, soft surfaces, and medical instruments. These compositions can be converted to solid particulate or granular compositions. These compositions can be put into a variety of containers which preserve the stability. These compositions can be used to treat allergens and molds and as part of a mold detection system. These compositions can be dispersed into the air to enable microbiological control. | 06-11-2009 |
20100311179 | Method of Using 14C Measurements to Determine the Percent Natural of Cleaning Compositions - The present invention relates to a method for measuring the percentage natural of a cleaning composition using radiocarbon dating data. The percentage natural of a cleaning composition is defined as the amount of material that comes from non-petroleum based or derived products. By using radiocarbon data for the entire composition or its individual components one can determine the percentage of materials which are from non-petroleum based or derived products, and calculate the percent Renewable Carbon Index (RCI). The percent RCI can be used to calculate the percent natural of the cleaning composition as defined by the methods of the present invention. | 12-09-2010 |
Patent application number | Description | Published |
20150133360 | MESITYLENE SULFONATE COMPOSITIONS AND METHODS THEREOF - The invention relates to compositions including a hypohalite or hypochlorous acid and a soluble salt of 2,4,6 mesitylene sulfonate. The compositions may include a surfactant, a buffer, or combinations thereof. Other adjuvants may also be present. Such compositions do not require the inclusion of high concentrations of sodium hydroxide or other soluble hydroxide salts to drastically increase pH (and thus stability), although such hydroxides may be present if desired. | 05-14-2015 |
20150133361 | MESITYLENE SULFONATE COMPOSITIONS AND METHODS FOR CLEANING A SURFACE - The invention relates to compositions including a hypohalite or hypochlorous acid and a soluble salt of 2,4,6 mesitylene sulfonate. The compositions may include a surfactant, a buffer, or combinations thereof. Other adjuvants may also be present. Such compositions do not require the inclusion of high concentrations of sodium hydroxide or other soluble hydroxide salts to drastically increase pH (and thus stability), although such hydroxides may be present if desired. | 05-14-2015 |
20150184113 | LIQUID MESITYLENE SULFONATE COMPOSITIONS AND METHODS THEREOF - The invention relates to compositions including a hypohalite or hypochlorous acid and a soluble salt of 2,4,6 mesitylene sulfonate. The compositions may include a surfactant, a buffer, or combinations thereof. Other adjuvants may also be present. Such compositions do not require the inclusion of high concentrations of sodium hydroxide or other soluble hydroxide salts to drastically increase pH (and thus stability), although such hydroxides may be present if desired. | 07-02-2015 |
20150184114 | METHOD FOR BLEACHING A SURFACE WITH A MESITYLENE SULFONATE COMPOSITION - The invention relates to compositions including a hypohalite or hypochlorous acid and a soluble salt of 2,4,6 mesitylene sulfonate. The compositions may include a surfactant, a buffer, or combinations thereof. Other adjuvants may also be present. Such compositions do not require the inclusion of high concentrations of sodium hydroxide or other soluble hydroxide salts to drastically increase pH (and thus stability), although such hydroxides may be present if desired. | 07-02-2015 |
Patent application number | Description | Published |
20090280176 | CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM - A controlled release formulation of alprazolam for once a day administration to a mammalian subject, which formulation releases alprazolam along a pre-determined release profile, is provided. | 11-12-2009 |
20090304794 | CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLE - A controlled release formulation of pramipexole for once-a-day administration to a mammalian subject, which formulation releases pramipexole along a pre-determined release profile, is provided. | 12-10-2009 |
20110003870 | METHOD OF TREATMENT OF A NEUROLOGICAL DISORDER - A method of treating neurological conditions, such as Parkinson's Disease and Restless Leg Syndrome, in a mammalian subject is disclosed. The method comprises the administration of a once-a-day controlled release formulation of pramipexole, which formulation provides a consistently ascending PK profile during sleeping hours. | 01-06-2011 |
20110244042 | STABILIZED FORMULATIONS OF CNS COMPOUNDS - Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone. | 10-06-2011 |
20110287099 | Sustained-release formulations of topiramate - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 11-24-2011 |
20110287103 | Sustained-release formulations of topiramate - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 11-24-2011 |
20120321708 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 12-20-2012 |
20130202661 | FORMULATIONS OF VILOXAZINE - Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed. | 08-08-2013 |
20140322343 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 10-30-2014 |
20150017249 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 01-15-2015 |
20150086629 | STABILIZED FORMULATIONS OF CNS COMPOUNDS - Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone. | 03-26-2015 |
20160022596 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE - Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. | 01-28-2016 |